Outcomes after precision prostatectomy: safety, efficacy and transference of skills.
Erectile dysfunction
Minimally invasive surgical procedures
Prostate cancer
Prostatectomy
Robotics
Urinary incontinence
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
10 Jul 2024
10 Jul 2024
Historique:
received:
15
03
2024
accepted:
20
05
2024
medline:
10
7
2024
pubmed:
10
7
2024
entrez:
10
7
2024
Statut:
epublish
Résumé
Precision Prostatectomy (PP) is a viable treatment option for men with unilateral dominant cancer who are interested in preserving functional outcomes. To date, the data published about the outcomes of this technique has come from a single center only (Henry Ford - HF). We present the surgical, functional, and oncological outcomes of the first series of patients to undergo PP outside of HF, to demonstrate the safety and reproducibility of the technique. Between 2022 and 2023, PP was offered to select patients who were interested in preserving their functional status. Men who underwent PP were followed at 3 monthly intervals; information regarding their functional status was simultaneously obtained. Men who had biochemical recurrence were advised to undergo remnant biopsy. If residual cancer was detected, then remnant removal was performed. The median age and median PSA of the study group was 63 years and 6.89 ng/ml respectively. The median operative and console times were 196.5 and 154 minutes. No intra-operative complications were noted. Three patients had a total of three post-operative complications. Three patients had biochemical recurrence; cancer was not detected in any of these patients on postoperative biopsies of the prostatic remnant. At 12 months, 91% of patients reported using 0 pads/day and 90.9% of pre-operatively potent patients were potent at 12 months. PP is a safe and reproducible technique that can ensure cancer control and preservation of functional status in select patients. Further studies with large sample sizes and longer follow-up are required to ascertain the long-term outcomes of this surgical technique.
Identifiants
pubmed: 38985306
doi: 10.1007/s00345-024-05074-2
pii: 10.1007/s00345-024-05074-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
394Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Cancer J Clin 73(1):17–48. https://doi.org/10.3322/caac.21763
doi: 10.3322/caac.21763
Menon M, Shrivastava A, Tewari A, Sarle R, Hemal A, Peabody JO, Vallancien G (2002) Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol. ;168(3):945-9. https://doi.org/10.1016/S0022-5347(05)64548-X . PMID: 12187196
Sood A, Grauer R, Diaz-Insua M, Tewari AK, Hemal AK, Shrivastava A, Peabody JO, Jeong W, Abdollah F, Rudzinski JK, Andrews JR, Gorin MA, Bhandari M, Menon M (2023) 15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer. Prostate Cancer Prostatic Dis 26(4):778–786. https://doi.org/10.1038/s41391-023-00674-2
doi: 10.1038/s41391-023-00674-2
pubmed: 37142635
Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF (2017) Association between Radiation Therapy, surgery, or Observation for localized prostate Cancer and patient-reported outcomes after 3 years. JAMA 317(11):1126–1140. https://doi.org/10.1001/jama.2017.1704
doi: 10.1001/jama.2017.1704
pubmed: 28324093
pmcid: 5782813
Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, Blazeby JM, Peters TJ, Holding P, Bonnington S, Lennon T, Bradshaw L, Cooper D, Herbert P, Howson J, Jones A, Lyons N, Salter E, Thompson P, Tidball S (2016) Patient-reported outcomes after monitoring, surgery, or Radiotherapy for prostate Cancer. N Engl J Med 375(15):1425–1437. https://doi.org/10.1056/NEJMoa1606221 . … ProtecT Study Group*
doi: 10.1056/NEJMoa1606221
pubmed: 27626365
pmcid: 5134995
Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, Mulhall JP (2019) Are we improving erectile function recovery after radical prostatectomy? Analysis of patients treated over the last decade. Eur Urol 75(2):221–228. https://doi.org/10.1016/j.eururo.2018.08.039
doi: 10.1016/j.eururo.2018.08.039
pubmed: 30237021
Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF (2013) Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 368(5):436–445. https://doi.org/10.1056/NEJMoa1209978
doi: 10.1056/NEJMoa1209978
pubmed: 23363497
pmcid: 3742365
Carbonara U, Srinath M, Crocerossa F, Ferro M, Cantiello F, Lucarelli G, Porpiglia F, Battaglia M, Ditonno P, Autorino R (2021) Robot-assisted radical prostatectomy versus standard laparoscopic radical prostatectomy: an evidence-based analysis of comparative outcomes. World J Urol 39(10):3721–3732. https://doi.org/10.1007/s00345-021-03687-5
doi: 10.1007/s00345-021-03687-5
pubmed: 33843016
Tewari AK, Ali A, Metgud S, Theckumparampil N, Srivastava A, Khani F, Robinson BD, Gumpeni N, Shevchuk MM, Durand M, Sooriakumaran P, Li J, Leung R, Peyser A, Gruschow S, Asija V, Harneja N (2013) Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing. World J Urol. ;31(3):471 – 80. https://doi.org/10.1007/s00345-012-1018-7 . Epub 2013 Jan 26. PMID: 23354288
Reddy D, Peters M, Shah TT, van Son M, Tanaka MB, Huber PM, Lomas D, Rakauskas A, Miah S, Eldred-Evans D, Guillaumier S, Hosking-Jervis F, Engle R, Dudderidge T, Hindley RG, Emara A, Nigam R, McCartan N, Valerio M, Afzal N, Lewi H, Orczyk C, Ogden C, Shergill I, Persad R, Virdi J, Moore CM, Arya M, Winkler M, Emberton M, Ahmed HU (2022) Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. Eur Urol. ;81(4):407–413. https://doi.org/10.1016/j.eururo.2022.01.005 . Epub 2022 Feb 3. PMID: 35123819
Mortezavi A, Krauter J, Gu A, Sonderer J, Bruhin J, Reeve KA, Held L, Donati OF, Rupp NJ, Moch H, Sulser T, Eberli D (2019) Extensive histological sampling following focal therapy of clinically significant prostate Cancer with high intensity focused Ultrasound. J Urol 202(4):717–724. https://doi.org/10.1097/JU.0000000000000298
doi: 10.1097/JU.0000000000000298
pubmed: 31042109
Sood A, Jeong W, Taneja K, Abdollah F, Palma-Zamora I, Arora S, Gupta N, Menon M (2019) The Precision Prostatectomy: an IDEAL stage 0, 1 and 2a study. BMJ Surg Interventions Health Technol 1(1):e000002. https://doi.org/10.1136/bmjsit-2019-000002
doi: 10.1136/bmjsit-2019-000002
Sood A, Abdollah F, Jeong W, Menon M (2020) The Precision Prostatectomy: Waiting for Godot. Eur Urol Focus 6(2):227–230. https://doi.org/10.1016/j.euf.2020.01.010
doi: 10.1016/j.euf.2020.01.010
pubmed: 31983662
Sood A, Jeong W, Keeley J, Abdollah F, Hassan O, Gupta N, Menon M (2021) Subtotal surgical therapy for localized prostate cancer: a single-center precision prostatectomy experience in 25 patients, and SEER-registry data analysis. Translational Androl Urol 10(7):3155–3166. https://doi.org/10.21037/tau-20-1476
doi: 10.21037/tau-20-1476
Sood A, Jeong W, Palma-Zamora I, Abdollah F, Butaney M, Corsi N, Wurst H, Arora S, Kachroo N, Hassan O, Gupta N, Gorin MA, Menon M (2022) Description of Surgical technique and oncologic and functional outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1-2b study). Eur Urol 81(4):396–406. https://doi.org/10.1016/j.eururo.2021.10.017
doi: 10.1016/j.eururo.2021.10.017
pubmed: 34872786
Galimberti V, Morigi C, Bagnardi V, Corso G, Vicini E, Fontana SKR, Naninato P, Ratini S, Magnoni F, Toesca A, Kouloura A, Rietjens M, De Lorenzi F, Vingiani A, Veronesi P (2018) Oncological outcomes of nipple-sparing mastectomy: a single-center experience of 1989 patients. Ann Surg Oncol 25(13):3849–3857. https://doi.org/10.1245/s10434-018-6759-0
doi: 10.1245/s10434-018-6759-0
pubmed: 30225833
Tewari AK, Srivastava A, Huang MW, Robinson BD, Shevchuk MM, Durand M, Sooriakumaran P, Grover S, Yadav R, Mishra N, Mohan S, Brooks DC, Shaikh N, Khanna A, Leung R (2011) Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP). BJU Int. ;108(6 Pt 2):984 – 92. https://doi.org/10.1111/j.1464-410X.2011.10565.x . PMID: 21917101
Martini A, Gupta A, Lewis SC, Cumarasamy S, Haines KG 3rd, Briganti A, Montorsi F, Tewari AK (2018) Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int 122(6):1025–1033. https://doi.org/10.1111/bju.14353 Epub 2018 May 14. PMID: 29676063
Wagaskar VG, Mittal A, Sobotka S, Ratnani P, Lantz A, Falagario UG, Martini A, Dovey Z, Treacy PJ, Pathak P, Nair S, Roy B, Chakravarty D, Lewis S, Haines K 3rd, Wiklund P, Tewari A (2021) Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the space of Retzius and sparing the Pouch of Douglas, enabling early return of Continence without Compromising Surgical Margin Rates. Eur Urol 80(2):213–221. https://doi.org/10.1016/j.eururo.2020.09.044
Schlomm T, Tennstedt P, Huxhold C, Steuber T, Salomon G, Michl U, Heinzer H, Hansen J, Budäus L, Steurer S, Wittmer C, Minner S, Haese A, Sauter G, Graefen M, Huland H (2012) Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur Urol 62(2):333–340. https://doi.org/10.1016/j.eururo.2012.04.057 Epub 2012 May 10. PMID: 22591631
doi: 10.1016/j.eururo.2012.04.057
pubmed: 22591631
Pisansky TM, Thompson IM, Valicenti RK, D’Amico AV, Selvarajah S (2019) Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018–2019. J Urol 202(3):533–538. https://doi.org/10.1097/JU.0000000000000295
doi: 10.1097/JU.0000000000000295
pubmed: 31042111
pmcid: 8680266
Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, Guillaumier S, Hindley RG, Hosking-Jervis F, Leemann L, Lewi H, McCartan N, Moore CM, Nigam R, Odgen C, Persad R, Thalmann GN, Virdi J, Winkler M, Ahmed HU (2020) Prostate specific Antigen Criteria to diagnose failure of Cancer Control following focal therapy of nonmetastatic prostate Cancer using high intensity focused Ultrasound. J Urol 203(4):734–742 Epub 2020 Jan 13. PMID: 31928408
doi: 10.1097/JU.0000000000000747
pubmed: 31928408
Agarwal PK, Sammon J, Bhandari A, Dabaja A, Diaz M, Dusik-Fenton S, Satyanarayana R, Simone A, Trinh QD, Baize B, Menon M (2011) Safety profile of robot-assisted radical prostatectomy: a standardized report of complications in 3317 patients. Eur Urol 59(5):684–698. https://doi.org/10.1016/j.eururo.2011.01.045
doi: 10.1016/j.eururo.2011.01.045
pubmed: 21324583
Rabbani F, Yunis LH, Pinochet R, Nogueira L, Vora KC, Eastham JA, Guillonneau B, Laudone V, Scardino PT, Touijer K (2010) Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. Eur Urol 57(3):371–386. https://doi.org/10.1016/j.eururo.2009.11.034
doi: 10.1016/j.eururo.2009.11.034
pubmed: 19945779
Bratan F, Melodelima C, Souchon R, Hoang Dinh A, Mège-Lechevallier F, Crouzet S, Colombel M, Gelet A, Rouvière O (2015) How accurate is multiparametric MR imaging in evaluation of prostate cancer volume? Radiology 275(1):144–154. https://doi.org/10.1148/radiol.14140524 Epub 2014 Nov 21. PMID: 25423145
doi: 10.1148/radiol.14140524
pubmed: 25423145
Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T, Hosking-Jervis F, Hindley RG, Lewi H, McCartan N, Moore CM, Nigam R, Ogden C, Persad R, Shah K, van der Meulen J, Virdi J, Winkler M, Emberton M, Ahmed HU (2018) A Multicentre Study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate Cancer. Eur Urol 74(4):422–429 Epub 2018 Jun 28. PMID: 29960750; PMCID: PMC6156573
doi: 10.1016/j.eururo.2018.06.006
pubmed: 29960750
pmcid: 6156573
Bründl J, Osberghaus V, Zeman F, Breyer J, Ganzer R, Blana A, Gierth M, Denzinger S, Burger M, Rosenhammer B (2022) Oncological long-term Outcome after whole-gland high-intensity focused Ultrasound for prostate Cancer-21-yr follow-up. Eur Urol Focus 8(1):134–140 Epub 2021 Jan 20. PMID: 33483288
doi: 10.1016/j.euf.2020.12.016
pubmed: 33483288
Westhoff N, Ernst R, Kowalewski KF, Schmidt L, Worst TS, Michel MS, von Hardenberg J (2021) Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer. World J Urol 39(4):1121–1129. https://doi.org/10.1007/s00345-020-03301-0 Epub 2020 Jun 12. PMID: 32533247; PMCID: PMC8124049
doi: 10.1007/s00345-020-03301-0
pubmed: 32533247
Fanshawe JB, Wai-Shun Chan V, Asif A, Ng A, Van Hemelrijck M, Cathcart P, Challacombe B, Brown C, Popert R, Elhage O, Ahmed K, Brunckhorst O, Dasgupta P (2023) Decision Regret in Patients with Localised Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. ;6(5):456–466. doi: 10.1016/j.euo.2023.02.005. Epub 2023 Mar 3. PMID: 36870852